Switzerland· 58572001
Soluprick SQ Artemisia vulgaris, Pricktestlösung
A tests for allergic diseases product containing pollinis allergeni extractum (artemisia vulgaris), registered in Switzerland by ALK-Abelló AG and dispensed under Swissmedic category A. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Pollinis allergeni extractum (artemisia vulgaris) is registered in 11 of 19 countries.
Countries holding a registration under ATC V04CL (tests for allergic diseases), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Pollinis allergeni extractum (artemisia vulgaris) · ATC V04CL
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- pollinis allergeni extractum (artemisia vulgaris)
- Manufacturer
- ALK-Abelló AG
- Country
- Switzerland (CH)
- ATC code
- V04CL
- ATC class
- Tests for allergic diseases
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pollinis allergeni extractum (artemisia vulgaris) in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesArtemisia vulgarisBoiron
- GermanyAlk-Prick SqAlk-Abelló Arzneimittel Gmbh
- United KingdomMugwort (Artemisia vulgaris) pollen 10,000DU/ml ODC solution for skin prick testAllergy Therapeutics (UK) Ltd
- NetherlandsArtemisia vulgarisBoiron
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Czechia · Soluprick Sq
- Germany · Alk-Prick Sq, Gemeiner Beifuß Hal Allergy
- Denmark · Soluprick Sq
- Finland · Soluprick Sq
- United Kingdom (Northern Ireland) · Soluprick Sq
- Netherlands · Soluprick Sq
- Poland · Bylica Pospolita Prick Test Hal Allergy
- Sweden · Soluprick Sq
- Slovakia · Soluprick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d9bcb3c-3b91-4182-ba9b-15cbe23dc963 GET /v1/drugs/5d9bcb3c-3b91-4182-ba9b-15cbe23dc963?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Allergen: Diagnostikum"
}See everything about pollinis allergeni extractum (artemisia vulgaris).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.